NCAB Says President’s Budget Would “Seriously Damage” Cancer Program
In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says
Biology Societies Recomend 15% Funding Increase for NIH
Clinical Trials: Data Manager Falsified NSABP Records On 3 Patients, ORI Says
Letter to The Editor: IOM Panel Urges Greater Integration Of Research
Funding Opportunities: NCI Accepts apploications For Cooperative Group Awards
Trending Stories
- Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group - Lou Weiner: Poetry and art help us imagine my mother’s world as a hidden child of the Holocaust
- ACOG says it will no longer accept federal funding
- Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s Mercy
Whistleblower lawsuit alleges wrongful firing - When public service ends abruptly, do books provide solace? An escape? Perspective?
Former NIH and FDA employees tell us what they are reading in 2025 - Andrea Werblin Reid’s unflinching poetry documents the realities of cancer care, clinical trials, and loss
Her collection, “To See Yourself As You Vanish,” will be published three years after her death
